Dose Proportionality and Food Effect of Morphine Sulfate
NCT00994539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2018-01-23
Summary
Establish the dose proportionality of the 15 mg and 30 mg morphine sulfate tablets and to examine the effect of food on absorption from the 30 mg tablet.
Conditions
Interventions
- DRUG
-
morphine sulfate
morphine sulfate 15 mg and 30 mg tablets
Sponsors & Collaborators
-
Roxane Laboratories
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-02-28
- Completion
- 2007-02-28
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess How the Body Processes a Strong Painkiller When it is Given Alongside a Drug That Counteracts the Side Effects of Strong Painkillers in a Fasted and Fed State.
NCT02133820 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions
NCT00759356 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects
NCT01322360 ·Status: COMPLETED ·Phase: PHASE4
-
Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone
NCT01456507 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions
NCT00759759 ·Status: COMPLETED ·Phase: PHASE1
-
Taste Acuity and Caloric Intake After Acute Morphine Administration
NCT01763697 ·Status: COMPLETED ·Phase: NA
-
A Study of Whether 2 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT02089581 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects
NCT04683926 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen
NCT02848729 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics And Relative Bioavailability Study Of Oxycodone in Healthy Volunteers
NCT01717027 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Oral Morphine Sulfate Administration in Pediatric Subjects
NCT03429400 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers
NCT00802308 ·Status: COMPLETED ·Phase: PHASE1
-
Cannabidiol, Morphine, Pain
NCT04030442 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain
NCT01676493 ·Status: TERMINATED ·Phase: PHASE3
-
Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine
NCT00256347 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
NCT05219669 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects
NCT06636500 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Whether 3 New Oral Formulations of a Strong Pain Killer Release the Same Amount of Drug Into the Body as the Marketed Medication
NCT02446561 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery
NCT00390039 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)
NCT00474799 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning
NCT00930943 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
NCT02750748 ·Status: COMPLETED ·Phase: PHASE1
-
Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo
NCT01595867 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers
NCT03129347 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants
NCT04448561 ·Status: COMPLETED ·Phase: PHASE1